Regulatory Updates
Aug 30, 2026•1 min read
Korea advances legal framework for medical cannabis to aid rare disease patients
A policy forum at the National Assembly discussed establishing a legal basis for introducing and producing cannabis‑derived medicines to ensure stable supply for rare and intractable disease patients.
Regulatory Updates
Aug 30, 2026•1 min read
32 New Drugs Added to Korea Health Insurance Reimbursement List in H1 2024
32 drugs were newly listed or had expanded coverage, benefiting about 76,600 patients and costing roughly 741 billion KRW annually.
1
Regulatory Updates
Aug 30, 2026•1 min read
South Korea launches fast‑track health‑insurance listing pilot for rare disease drugs
The Ministry of Health and Welfare aims to cut the health‑insurance listing period for rare‑disease therapies from up to 240 days to within 100 days, initially covering about five drugs.